Evidence map›Paper›PMID 37304721›Full record

ArticleFrontiers in plant science2023

Machine learning enhances prediction of plants as potential sources of antimalarials.

Adam Richard-Bollans, Conal Aitken, Alexandre Antonelli, Cássia Bitencourt, David Goyder, Eve Lucas, Ian Ondo, Oscar A Pérez-Escobar, Samuel Pironon, James E Richardson and 4 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in plant science, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
3.6field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 7 institutions in 5 countries.

Adam Richard-BollansRoyal Botanic Gardens, Kew, Richmond, United Kingdom.
Conal AitkenRoyal Botanic Gardens, Kew, Richmond, United Kingdom.
Alexandre AntonelliRoyal Botanic Gardens, Kew, Richmond, United Kingdom.
Cássia BitencourtRoyal Botanic Gardens, Kew, Richmond, United Kingdom.
David GoyderRoyal Botanic Gardens, Kew, Richmond, United Kingdom.
Eve LucasRoyal Botanic Gardens, Kew, Richmond, United Kingdom.
Ian OndoRoyal Botanic Gardens, Kew, Richmond, United Kingdom.
Oscar A Pérez-EscobarRoyal Botanic Gardens, Kew, Richmond, United Kingdom.
Samuel PirononRoyal Botanic Gardens, Kew, Richmond, United Kingdom.
James E RichardsonSchool of Biological, Earth and Environmental Sciences, University College Cork, Cork, Ireland.
David RussellRoyal Botanic Gardens, Kew, Richmond, United Kingdom.
Daniele SilvestroGothenburg Global Biodiversity Centre, Department of Biological and Environmental Sciences, University of Gothenburg, Gothenburg, Sweden.
Colin W WrightSchool of Pharmacy and Medical Sciences, University of Bradford, Bradford, United Kingdom.
Melanie-Jayne R HowesRoyal Botanic Gardens, Kew, Richmond, United Kingdom.
Royal Botanic Gardens, Kew · GBKing's College London · GBSIB Swiss Institute of Bioinformatics · CHUniversidad del Rosario · COUniversity of Bradford · GBUniversity of Gothenburg · SEWorld Conservation Monitoring Centre · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Plants are a rich source of bioactive compounds and a number of plant-derived antiplasmodial compounds have been developed into pharmaceutical drugs for the prevention and treatment of malaria, a major public health challenge. However, identifying plants with antiplasmodial potential can be time-consuming and costly. One approach for selecting plants to investigate is based on ethnobotanical knowledge which, though having provided some major successes, is restricted to a relatively small group of plant species. Machine learning, incorporating ethnobotanical and plant trait data, provides a promising approach to improve the identification of antiplasmodial plants and accelerate the search for new plant-derived antiplasmodial compounds. In this paper we present a novel dataset on antiplasmodial activity for three flowering plant families - Apocynaceae, Loganiaceae and Rubiaceae (together comprising c. 21,100 species) - and demonstrate the ability of machine learning algorithms to predict the antiplasmodial potential of plant species. We evaluate the predictive capability of a variety of algorithms - Support Vector Machines, Logistic Regression, Gradient Boosted Trees and Bayesian Neural Networks - and compare these to two ethnobotanical selection approaches - based on usage as an antimalarial and general usage as a medicine. We evaluate the approaches using the given data and when the given samples are reweighted to correct for sampling biases. In both evaluation settings each of the machine learning models have a higher precision than the ethnobotanical approaches. In the bias-corrected scenario, the Support Vector classifier performs best - attaining a mean precision of 0.67 compared to the best performing ethnobotanical approach with a mean precision of 0.46. We also use the bias correction method and the Support Vector classifier to estimate the potential of plants to provide novel antiplasmodial compounds. We estimate that 7677 species in Apocynaceae, Loganiaceae and Rubiaceae warrant further investigation and that at least 1300 active antiplasmodial species are highly unlikely to be investigated by conventional approaches. While traditional and Indigenous knowledge remains vital to our understanding of people-plant relationships and an invaluable source of information, these results indicate a vast and relatively untapped source in the search for new plant-derived antiplasmodial compounds.

Indexed as

antiplasmodial activitybotanyethnobotanyethnopharmacologymachine learningmalariasampling biastraditional and indigenous knowledge

Identifiers

PMID37304721
PMCPMC10248027
OpenAlexW4378232541

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.